New: EULAR Points to consider for remote care in RMDs

This is the lay version of the EULAR points to consider for remote care in people with rheumatic and musculoskeletal diseases. The original publication can be downloaded from the EULAR website: www.eular.org. De Thurah A, Bosch P, Marques A, et al2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases Annals of […]

Read More…

High steroid-free success rates after glucocorticoid bridging

90% of people with early rheumatoid arthritis are steroid-free 2 years after bridging therapy INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, and may cause pain and disability. Rheumatoid arthritis can affect people of all ages, but it most often starts between the ages of 40 and 60. Rheumatoid arthritis […]

Read More…

Fully vaccinated people with systemic rheumatic diseases have less severe COVID outcomes

Breakthrough COVID-19 had lower hospitalisation and mortality in vaccinated patients INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people to change their behaviours to try to limit […]

Read More…

Comparison of heart attack risk across biologic DMARDs

The risk of acute coronary syndrome varies little across individual bDMARDs in people with rheumatoid arthritis INTRODUCTION Rheumatoid arthritis (shortened to RA) is a chronic inflammatory disease that affects a person’s joints, and may cause pain and disability. RA can affect people of all ages, but the risk increases with age. RA is more common […]

Read More…

Predicting treatment success in rheumatoid arthritis

Particularly in early disease, prediction can be achieved for people with lower baseline levels of diseases activity INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, and may cause pain and disability. Rheumatoid arthritis can affect people of all ages, but it most often starts between the ages of 40 and […]

Read More…

Over time, joint swelling recurs in the same joints in people with RA

The results suggest that local factors influence joint inflammation over time. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, and may cause pain and disability. Rheumatoid arthritis can affect people of all ages, but it most often starts between the ages of 40 and 50 – although this can depend […]

Read More…

Steroid dose and duration linked to cardiovascular events in RA

Dose and duration are associated with an increased risk for incident cardiovascular events in steroid-naïve patients INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, and may cause pain and disability. Rheumatoid arthritis can affect people of all ages, but it most often starts between the ages of 30 and 50 […]

Read More…

First study to show inflammatory arthritis can affect male fertility

Men diagnosed with inflammatory arthritis before and during the peak of reproductive age have lower fertility. INTRODUCTION Inflammatory arthritis is a group of diseases including spondyloarthritis, rheumatoid arthritis, and psoriatic arthritis. These are chronic inflammatory diseases that affects a person’s joints, and may cause pain and disability. Inflammatory arthritis can affect people before or during […]

Read More…

Methotrexate associated with reduced risk of cardiovascular disease in RA

Methotrexate-related mechanisms may modify cardiovascular risk in people with rheumatoid arthritis. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, and may cause pain and disability. Rheumatoid arthritis can affect people of all ages. It most often starts between the ages of 30 and 50 – although this can depend on […]

Read More…

Medication use for rheumatoid arthritis affects COVID-19 outcomes

People with rheumatoid arthritis treated with rituximab or JAKi have worse COVID-19 severity than those on TNFi INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people to […]

Read More…